August 06, 2026 — RNews

#prostate cancer — Thursday, August 06, 2026 (1 items)

hot top new

← prev day next day →

0

[(177)Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial. (linkinghub.elsevier.com)

Tagawa ST … Morris MJ The Lancet 2026-08-06

#prostate cancer #clinical trial #radiotherapy #immunotherapy